Webb1 juli 2024 · The Warrants may be exercised for $15.17 per share of our common stock (or $0.1198 per Warrant) and may be deemed exercised on a cashless basis at our … WebbSalarius Pharmaceuticals, Inc. (SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need... U.S....
Home - Salarius
WebbThis Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names … WebbSalarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference. HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in … rdu airport overnight parking
SLRX Stock Forecast, Price & News (Salarius Pharmaceuticals)
Webb17 mars 2024 · SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list Create SLRX Alert After Hours Last Updated: Mar 17, 2024 7:50 p.m. EDT Delayed quote $ 2.0700 0.07 3.50% After Hours Volume: 200... Webb24 mars 2024 · SLRX ($2.11) is significantly undervalued by 78.01% relative to our estimate of its Fair Value price of $9.59 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety Significantly Below Fair Value Valuation SLRX is unprofitable, so we... subscribe to Premium to read more. Webb13 apr. 2024 · About SLRX. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. how to spell skunk in spanish